Benefit and risk from paclitaxel-coated balloon angioplasty for the treatment of femoropopliteal artery disease: A systematic review and meta-analysis of randomised controlled trials

BACKGROUND: Paclitaxel-coated balloons (DCB) are suitable to reduce the risk of restenosis after angioplasty of atherosclerotic femoropopliteal lesions. However, numerous types of DCBs are distinguished by drug density and coating. Conflicting evidence exists about the risk of mortality. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Klumb, Christof, Lehmann, Thomas, Aschenbach, René, Eckardt, Niklas, Teichgräber, Ulf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890981/
https://www.ncbi.nlm.nih.gov/pubmed/31832619
http://dx.doi.org/10.1016/j.eclinm.2019.09.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890981/
https://www.ncbi.nlm.nih.gov/pubmed/31832619
http://dx.doi.org/10.1016/j.eclinm.2019.09.004

Ejemplares similares